Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

(3R,12aS)-3-(4-aminobutyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, and preparation and application thereof

A 3-b, diketone technology, applied in the field of biomedicine, can solve problems such as no effect

Inactive Publication Date: 2016-01-27
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF2 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Unfortunately, it does nothing for tumor complications

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • (3R,12aS)-3-(4-aminobutyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, and preparation and application thereof
  • (3R,12aS)-3-(4-aminobutyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, and preparation and application thereof
  • (3R,12aS)-3-(4-aminobutyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, and preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1 prepares 3S-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid (1)

[0024] Add 0.4 mL of concentrated sulfuric acid into 800 mL of distilled water, stir evenly, add 10 g of L-Trp, and sonicate to aid dissolution; add 20 mL of formaldehyde solution to the reaction solution, and stir at room temperature for 10 hours. Post-processing: add concentrated ammonia water dropwise to the reaction solution to adjust the pH to 6, let it stand still, a colorless solid precipitates, filter and dry to obtain 11.32 g of the crude product. ESI-MS (m / e): 215 [M-H] - .

Embodiment 2

[0025] Example 2 Preparation of 3S-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester (2)

[0026] Add 60mL of methanol to a 250mL reaction flask, add 7mL of thionyl chloride dropwise under ice bath, activate for 30 minutes, add 6.2g of 3S-1,2,3,4-tetrahydro-β-carboline-3- Carboxylic acid (1), stirred at room temperature overnight, TLC showed that the starting material basically disappeared. Post-processing: remove the solvent under reduced pressure, dissolve the residue with 100 mL of ethyl acetate, adjust the pH to 8 with triethylamine, and purify by silica gel column chromatography (CH 2 Cl 2 :CH 3 OH=100:1-20:1), yielding 4.625 g (70%) of methyl 3S-1,2,3,4-tetrahydro-β-carboline-3-carboxylate as a colorless solid. ESI-MS(m / e): 231[M+H] + .

Embodiment 3

[0027] Example 3 Preparation of 3S-1,2,3,4-tetrahydro-β-carboline-2-(D-Boc-benzyloxycarbonyllysyl)-3-carboxylic acid methyl ester (3)

[0028]Suspend 1.9g (5.0mmol) D-Boc-Lys(Z) in 20mL of anhydrous tetrahydrofuran, add 0.675g (5.0mmol) HOBt to the solution with stirring at room temperature, add 1.133g (5.5mmol) DCC while stirring in an ice bath , to obtain reaction solution I, stirred under ice bath for 30 minutes; 1.15g (5.0mmol) 3S-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester (2) was suspended in In 20 mL of anhydrous tetrahydrofuran, the reaction solution II was obtained; the reaction solution II was added to the reaction solution I, stirred for 1 h under ice bath, and stirred overnight at room temperature. Post-treatment: remove DCU by filtration under reduced pressure, concentrate the filtrate under reduced pressure to remove tetrahydrofuran, dissolve the residue with 150mL ethyl acetate, put the obtained solution in a 250mL separatory funnel, and succes...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a micromolecule mu-PA inhibitor (3R,12aS)-3-(4-aminobutyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione with the structural formula shown in the specification, relates to a preparation method of the compound and application of the compound to inhibit tumor invasion and migration, resist coagulation and diminish inflammation as the mu-PA inhibitor. The invention belongs to the field of biological medicine.

Description

technical field [0001] The present invention relates to the small molecule u-PA inhibitor (3S, 6'R)-tetrahydrocarboline [2, 3-b] and [3', 4'-b]-6'-( 1-aminobutyl-4-yl)-piperazine-2', 5'-dione, relates to its preparation method and its application as u-PA inhibitor in inhibiting tumor invasion and migration, anti-inflammation and anti-thrombosis. The invention belongs to the field of biomedicine. [0002] Background technique [0003] The plasminogen activation system consists of plasminogen activators (Pas), plasminogen activation inhibitors (PAIs) and extracellular plasminogen activator receptors (PAR). The plasminogen activation system is involved in a series of processes such as cell migration, angiogenesis, wound healing, embryonic development, tumor cell spread and metastasis. There are mainly two plasminogen activators in mammals, tissue plasminogen activator (t-PA) and urokinase plasminogen activator (u-PA). [0004] Urokinase-type plasminogen activator (u-PA) i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D471/14A61P35/04A61P35/00A61P29/00A61P7/02
Inventor 彭师奇赵明王玉记吴建辉王枫
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com